Log In
Print this Print this

4CMenB, Meningitis B vaccine

Also known as: MenB

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionMulticomponent meningococcal serogroup B vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationMeningitis
Indication DetailsPrevent meningococcal B meningitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today